NADH
Reduced β-Nicotinamide Adenine Dinucleotide (NADH) · also known as Reduced nicotinamide adenine dinucleotide, NADH, PANMOL-NADH, β-NADH
NADH is an endogenous electron donor for mitochondrial complex I. There is no direct evidence on whether oral supplementation reaches the mitochondria intact. Human studies so far mostly combined it with coenzyme Q10, so their results cannot be attributed to NADH alone.
Clinical uses and human evidence
Fatigue and energy
Studies (2)
Mechanisms of action
Monoamine neurotransmitter balance (dopamine, norepinephrine, 5-HT)
NADH takes part in the endogenous BH4 reduction cycle, a known biochemical reaction, but this does not mean that oral supplementation produces the same effect. No human study has shown that usual oral NADH increases brain BH4 regeneration, tyrosine hydroxylase activity, or synaptic dopamine.
Substrate and cofactor supply for glutathione (GSH) synthesis
In the body, NADH can be converted to NADPH through transhydrogenation, supplying electrons to glutathione reductase. This is endogenous metabolism. It is unclear whether oral NADH reaches this step, and no human study has shown that 10–20 mg taken orally increases tissue NADPH or glutathione reduction.